CWRU inks licensing deal to commercialize an imaging agent to aid in brain tumor surgery
Crain’s Cleveland Business (subscription required): Susann Brady-Kalnay, professor at the School of Medicine, talked about a new licensing agreement with a company called NeoIndicate to commercialize an imaging agent to aid in brain tumor surgery.
